Search research articles
Contact Us
Filters
Showing results (311-320 of 323) with videos related to
Page
of 33
Sort By:
Cancer
|
March 20, 2025
Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real-world setting: Interim results of the Italian observational study (ROMEI)
Massimo Breccia, Francesca Palandri, Maurizio Martelli, et al.
Therapeutic Advances in Hematology
|
March 16, 2023
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry
Monia Marchetti, Jon Salmanton-García, Shaimaa El-Ashwah, et al.
Frontiers in Immunology
|
March 13, 2023
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry
Alessandro Busca, Jon Salmanton-García, Francesco Marchesi, et al.
International Journal of Antimicrobial Agents
|
August 15, 2023
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry
Jon Salmanton-García, Francesco Marchesi, Philipp Koehler, et al.
Leukemia & Lymphoma
|
November 15, 2023
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey
Shaimaa El-Ashwah, Jon Salmanton-García, Yavuz M Bilgin, et al.
Frontiers in Oncology
|
October 24, 2022
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)
Maria Stefania Infante, Jon Salmanton-García, Ana Fernández-Cruz, et al.
Eclinicalmedicine
|
April 12, 2023
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry
Jon Salmanton-García, Francesco Marchesi, Maria Gomes da Silva, et al.
Cancers
|
November 26, 2022
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey
Chiara Cattaneo, Jon Salmanton-García, Francesco Marchesi, et al.
Blood
|
September 20, 2022
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
Livio Pagano, Jon Salmanton-García, Francesco Marchesi, et al.
Hematological Oncology
|
December 5, 2023
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry
Pellegrino Musto, Jon Salmanton-García, Nicola Sgherza, et al.
Page
of 33
Search research articles
Search
Showing results (311-320 of 323) with videos related to
Sort By:
Page
of 33
Cancer
|
March 20, 2025
Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real-world setting: Interim results of the Italian observational study (ROMEI)
Massimo Breccia, Francesca Palandri, Maurizio Martelli, et al.
Therapeutic Advances in Hematology
|
March 16, 2023
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry
Monia Marchetti, Jon Salmanton-García, Shaimaa El-Ashwah, et al.
Frontiers in Immunology
|
March 13, 2023
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry
Alessandro Busca, Jon Salmanton-García, Francesco Marchesi, et al.
International Journal of Antimicrobial Agents
|
August 15, 2023
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry
Jon Salmanton-García, Francesco Marchesi, Philipp Koehler, et al.
Leukemia & Lymphoma
|
November 15, 2023
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey
Shaimaa El-Ashwah, Jon Salmanton-García, Yavuz M Bilgin, et al.
Frontiers in Oncology
|
October 24, 2022
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)
Maria Stefania Infante, Jon Salmanton-García, Ana Fernández-Cruz, et al.
Eclinicalmedicine
|
April 12, 2023
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry
Jon Salmanton-García, Francesco Marchesi, Maria Gomes da Silva, et al.
Cancers
|
November 26, 2022
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey
Chiara Cattaneo, Jon Salmanton-García, Francesco Marchesi, et al.
Blood
|
September 20, 2022
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
Livio Pagano, Jon Salmanton-García, Francesco Marchesi, et al.
Hematological Oncology
|
December 5, 2023
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry
Pellegrino Musto, Jon Salmanton-García, Nicola Sgherza, et al.
Page
of 33